SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

United States

Beth Israel Deaconess Medical Center for Autonomic and Peripheral Nerve Disorders, Boston, Massachusetts

Ichan School of Medicine at Mount Sinai, New York, New York

University of Rochester, Rochester, New York

University of Pittsburgh, Pittsburgh, Pennsylvania

University of Utah, Salt Lake City, Utah

University of Vermont, Burlington, Vermont

VCU Medical Center, Richmond, Virginia